Patients Alleging Severe Health Issues From Ozempic Prompt Wave of Lawsuits, Seek Justice and Compensation
Philadelphia, PA — Legal teams are currently examining potential lawsuits against the makers of Ozempic, focusing on claims that the diabetes and weight loss drug has led to severe gastrointestinal issues, including gastroparesis. This condition, characterized primarily by delayed stomach emptying, can cause chronic and disabling symptoms like nausea and abdominal pain, materially impacting quality of life. Ozempic, known generically as semaglutide, is prescribed widely in the management of type 2 diabetes and as a weight loss aid. It functions by mimicking a hormone that signals the pancreas to release insulin, subsequently lowering blood sugar. … Read more